Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 25, 1998

View Archived Issues

Company Profile: Introgen Therapeutics

T Cell Sciences receives patent on new compound

New anticancer agent capable of eluding tumor resistance mechanisms

C. pneumoniae antibody titers correlated to stroke and cerebral ischemia

NOS inhibition with L-NMMA reduces CBF in humans

Cortex: Q2 fiscal 1998 highlights

Electroporation therapy results in at least 80% reduction in tumor volume in preclinical studies

Neurocrine Biosciences: Q4 and FY 1997 highights

TRH ineffective as treatment for lung problems in premature infants

Osiris and the University of Cincinnati expand collaboration in tendon regeneration

Biosearch Italia and Versicor establish infectious disease collaboration

Biogen sets up Canadian office to promote local development of Avonex

FDA advisory committee to vote on expanded label for CEPRATE SC System

Selective inhibitor of p38 MAP kinase effective in chronic inflammatory diseases

Nucleoside with potent and selective anti-HIV and anti-HBV activity

Tedisamil has favorable profile as myocardial antiischemic agent

Azithromycin prevents acceleration of atherosclerosis by C. pneumoniae infection

Roche acquisition of Corange approved by U.S. regulators

Another market introduction for Aricept

Lead compound from ABS shows promise for neurodegenerative disorders

Nonsteroidal human progesterone receptor agonists developed at Ligand

Improved vision in AMD patients in phase I/II using PhotoPoint technology

Dolasetron now available in U.S.

Orthovisc PMA accepted for filing by FDA

Glycomed antiinflammatory patents licensed to Cytel

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...